While psychedelics reform is clearly gaining momentum, not only in the U.S. but notably in places like Australia and less so Canada. The fact is, all compounds remain currently Schedule I drugs (or equivalents) and thus federally illegal in many countries including the U.S.

The regulatory advances on these substances have been joined by an also-clear change in public perception, which is not to say that psychedelics were unknown to people before. Now, they have effectively entered the mainstream and are being considered by a greater majority looking at their therapeutic potential as mental health treatments.

This is the case especially for psilocybin mushrooms, considering the numerous and acclaimed tales on microdosing’s

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.